Sarah Kim, Ph.D., an assistant professor of pharmaceutics in the University of Florida College of Pharmacy, has been awarded a three-year, $750,000 grant from JDRF to study improvements to pancreatic imaging.
Desmond Schatz, M.D., Professor and Interim Chair of the Department of Pediatrics, and Pediatric Medical Director of the University of Florida Diabetes Institute, has been selected as the recipient of the prestigious 2021 JDRF George Eisenbarth Award for Type 1 Diabetes Prevention. The award will be presented to Dr. Schatz…
In this episode of Wellness Talk, Ashby Walker, Ph.D., director for health equity initiatives at the UF Diabetes Institute, talks about diabetes awareness, prevention, and access equity. Dr. Walker’s research as a medical sociologist focuses on Type 1 Diabetes and the role that social capital plays in determining health outcomes.
World Diabetes Day is November 14th and this year’s theme is “Access to Diabetes Care.” Each year, the University of Florida Diabetes Institute (UFDI) celebrates “Bluevember” as a month to raise awareness about diabetes and reaffirm our commitment to improve the lives of people living with diabetes. And this year,…
To celebrate Diabetes Awareness Month, we are sharing a new series of animated shorts about Type 1 Diabetes called Kara Goes to School. In the next 14 days we…
Project ECHO Diabetes provides education and support to patients and providers across the state…
The announcement cements UF’s meteoric rise in rankings over the past five years and publicly recognizes the university’s excellence and value.
2021 marks the 100th year since Sir Frederick Banting, Charles Best, and Professor John Macleod from the University of Toronto reported the successful treatment of canine diabetes with a pancreas extract, now known as insulin. This discovery represented not only a remarkable scientific achievement, but more importantly, provided a life-saving…
Listen to Dr. Ashby Walker discuss the results of her groundbreaking study on barriers to Type 1 diabetes care on the ADA Journals podcast. Ashby Walker, PhD…
Experts recommend the use of continuous glucose monitors as the gold standard for managing Type 1 diabetes. Yet many adult patients, particularly those with lower socioeconomic status and from underrepresented minority groups, are not receiving the technology or regular care from specialists known as endocrinologists.
